Representatives of Georgia’s nascent medical cannabis industry are expressing frustration with the state’s process for issuing licenses to grow and process cannabis into a therapeutic oil used by registered patients for conditions including seizures and intractable pain.
Georgia legalized low-THC oil and products for people with certain conditions in 2015, but the state didn’t create a legal framework for production until last year. The Georgia Department of Public Health said there were 14,511 people on the Low THC Oil Registry in February 2020, according to Georgia Health News.
Since then, nearly 70 companies have applied for six licenses with the Georgia Access to Medical Cannabis Commission. The commission said in its annual report in January that licenses would be issued by the end of the fiscal year on June 30.
The commission’s executive director, Andrew Turnage, told Fresh Take Georgia last month that the commission was on track to announce “next steps” by the end of May. He has not responded to subsequent questions about the commission’s timeline, funding or staffing.
Read more at gpb.org.